Top editors picks!

Photo by Pavel Danilyuk from Pexels

Spruce Biosciences Soars With BTD For MPS IIIB Therapy TA-ERT

Photo by Tima Miroshnichenko from Pexels

MoonLake Posts Mixed Data For Sonelokimab For Patients With Hidradenitis Suppurativa

Photo by Edward Jenner from Pexels

Positive 3-Year AMT-130 Data For Huntington’s From uniQure Bodes Well For Pre-BLA Meeting

Photo by Artem Podrez from Pexels

Pfizer Acquires Metsera For $7.3 Billion For Differentiated Weight Loss Drug

Photo by Tima Miroshnichenko from Pexels

Kairos Posts Positive Interim Prostate Cancer Treatment Resistance Data With ENV105

Photo by Pavel Danilyuk from Pexels

Novartis To Acquire Tourmaline Bio For $1.4B For Novel IL-6 Inhibitor Pacibekitug

Photo by Tima Miroshnichenko from Pexels

Viking’s Stock Craters After Mid-Stage Obesity Trial Data With Oral Drug VK7235

Photo by Mikhail Nilov from Pexels

Precigen Scores FDA Approval Of Immunotherapeutic PAPZIMEOS For Rare Respiratory Disease

Novartis’ Win Streak With Ianalumab Continues With Solid ITP Treatment Data Release

Bicycle Reduces 25% Of Staff Amid Second Half Of 2025 Program Updates Expected

Eli Lilly’s Stock Price Drops As Oral GLP-1 Achieves Moderate Weight Loss In Late-Stage Testing

Tern Makes Shift In Pipeline To Cancer Asset TERN-701 As Obesity Space Gets Crowded

BioMarin Gets Rid Of Palynziq Successor To Treat PKU For Lack Of Goal Being Met

Vertex’s Phase 2 Failure Leaves Next-Gen VX-993 Pain Drug On The Chopping Block

Cardiff’s Onvansertib Shows To Be Helpful To RAS-Mutated Colorectal Cancer Patients

Merck’s $3 Billion Cost-Cutting Measure Is First Step For Intended Future Growth

FDA Alters Course On ELEVIDYS Shipping Pause For Ambulatory DMD Patients

CHMP Negative Opinion On ELEVIDYS Brings Further Woes For Sarepta And Its Partner Roche

Rocket Realigns Pipeline Towards Cardiovascular Targeting To Extend Cash Runway

Abivax’s Successful Phase 3 Ulcerative Colitis Trial Shows Obefazimod Differentiation

Scroll to Top